US is drafting plans for sale of some unapproved peptides, the Washington Post reports
The Trump administration is drafting plans for the temporary sale of some unapproved peptides, the Washington Post reported on Thursday.
(Reporting by Jasper Ward and Christian Martinez; Editing by Muralikumar Anantharaman)
Google News